Protocol Summary

Protocol No.

156598 (S2015)

Principal Investigator

Hyngstrom, John

Phase

III

Age Group

Adult

ClinicalTrials.Gov

NCT03860883 (Click to jump to clinicaltrials.gov)

Title

Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma

Objective

Applicable Disease Sites

Melanoma

Participating Institutions

Huntsman Cancer Institute

Status

Open


Clinical trials search powered by Forte Research Systems

FORTE